Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP4A | P20648 | 14/20 | 0.53 |
| ▸ | ATP4B | P51164 | 14/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.53 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | FASN | P49327 | 1/20 | 0.53 |
| ▸ | SLC47A2 | Q86VL8 | 1/20 | 0.53 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.53 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.53 |
| ▸ | ATP1A1 | P05023 | 7/20 | 0.45 |
| ▸ | ATP1B1 | P05026 | 7/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantoprazole SCHEMBL4192305 | 0.99 | ATP4A (0.54) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL29465 | 0.99 | ATP4A (0.54) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL6469440 | 0.99 | ATP4A (0.54) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL29425016 | 0.99 | ATP4A (0.54) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL4942069 | 0.99 | ATP4A (0.54) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL12662938 | 0.99 | ATP4A (0.54) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL3716300 | 0.98 | ATP4A (0.53) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL4320242 | 0.98 | ATP4A (0.53) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL6262319 | 0.98 | ATP4A (0.53) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL3542 | 0.98 | ATP4A (0.53) | ATP4AATP4BCYP2C9KDM4ESLC22A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102718751-B | Pantoprazole salt crystal form and preparation method thereof | Hangzhou zhongmei huadong pharmaceutical co ltd | 2014-02-19 | — | — | CN | claimed |
| CN-102718751-A | Pantoprazole salt crystal form and preparation method thereof | Hangzhou zhongmei huadong pharmaceutical co ltd | 2012-10-10 | — | — | CN | claimed |
| CN-1369491-A | Chiral pantorazole salt and its preparing process | UNIV SHENYANG PHARMACY (CN) | 2002-09-18 | — | — | CN | claimed |
| CN-113425717-B | Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof | 成都欧林生物科技股份有限公司 | 2023-06-16 | — | — | CN | disclosed |
| CN-113425717-A | Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof | 成都欧林生物科技股份有限公司 | 2021-09-24 | — | — | CN | disclosed |
| CN-104803983-B | A kind of compound of pantoprazole sodium and preparation thereof | 山东罗欣药业集团股份有限公司 | 2016-09-28 | — | — | CN | disclosed |
| CN-105213390-A | A kind of medicine pantoprazole composition of sodium for the treatment of peptic ulcer | YANG XIANMEI | 2016-01-06 | — | — | CN | disclosed |
| CN-105147616-A | Medicine namely pantoprazole sodium composition dry suspension for treating gastric ulcer | QINGDAO LANSHENGYANG PHARMACEUTICAL BIOTECHNOLOGY CO LTD | 2015-12-16 | — | — | CN | disclosed |
| CN-105106204-A | Medicinal pantoprazole sodium composition for treating digestive system diseases | QINGDAO HUAZHICAO MEDICAL TECHNOLOGY CO LTD | 2015-12-02 | — | — | CN | disclosed |
| CN-105078981-A | Freeze-dried powder injection of pantoprazole sodium composition for treating stomach illness | QINGDAO HUAZHICAO PHARMACEUTICAL TECHNOLOGY CO LTD | 2015-11-25 | — | — | CN | disclosed |
| CN-105055411-A | Pantoprazole sodium composition for treating gastric ulcer | QINGDAO HUAZHICAO PHARMACEUTICAL CO LTD | 2015-11-18 | — | — | CN | disclosed |
| CN-101961334-A | Combined drug of pantoprazole and domperidone | Chengdu zihao pharmaceutical co ltd | 2011-02-02 | — | — | CN | disclosed |
| CN-1835738-A | Pharmaceutical compositions having a swellable coating | REDDYS LAB INC DR (US) | 2006-09-20 | — | — | CN | disclosed |
| EP-1681052-A1 | Solid pharmaceutical dosage forms for reducing the bioavailability food effect | Dr. Reddy's Laboratories Ltd. (IN) | 2006-07-19 | — | — | EP | disclosed |
| EP-1601667-A2 | CRYSTALLINE AND AMORPHOUS SOLIDS OF PANTOPRAZOLE AND PROCESSES FOR THEIR PREPARATION | Teva Pharmaceutical Industries Limited (IL) | 2005-12-07 | — | — | EP | disclosed |
| US-20050147663-A1 | Method of treatment for improved bioavailability | DR. REDDY'S LABORATORIES, INC. | 2005-07-07 | — | — | US | disclosed |
| US-20050042277-A1 | Pharmaceutical compositions having a swellable coating | DR. REDDY'S LABORATORIES, INC. | 2005-02-24 | — | — | US | disclosed |
| US-20040235904-A1 | Crystalline and amorphous solids of pantoprazole and processes for their preparation | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-11-25 | — | — | US | disclosed |
| WO-2004080961-A2 | CRYSTALLINE AND AMORPHOUS SOLIDS OF PANTOPRAZOLE AND PROCESSES FOR THEIR PREPARATION | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-09-23 | — | — | WO | disclosed |
| CN-1369491-A | Chiral pantorazole salt and its preparing process | UNIV SHENYANG PHARMACY (CN) | 2002-09-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235904-A1 | Crystalline and amorphous solids of pantoprazole and processes for their preparation | CYP3A4, CYP2C19, CYP4B1 | ATP4A 245/4885ATP4B 156/4885CYP2C9 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.